Interpretable multi-instance heterogeneous graph network learning modelling CircRNA-drug sensitivity association

Mengting Niu1,2,3, Chunyu Wang4, Yaojia Chen1,5,6

  • 1Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, China.

BMC Biology
|May 14, 2025
PubMed
Abstract

Insights

Predicting drug sensitivity associations with circular RNAs (circRNAs) is vital for personalized medicine. A new method, MiGNN2CDS, leverages multi-instance learning and graph networks to accurately identify these crucial circRNA-drug relationships.

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Circular RNAs (circRNAs) influence drug sensitivity in human cells, impacting therapeutic outcomes.
  • Traditional experimental methods for identifying circRNA-drug sensitivity associations are inefficient and costly.
  • Accurate prediction of novel circRNA-drug sensitivity relationships is essential for advancing personalized medicine.

Purpose of the Study:

  • To develop an effective computational method for predicting circRNA-drug sensitivity associations.
  • To construct a heterogeneous graph network model integrating circRNA and drug features.
  • To enhance the accuracy and interpretability of circRNA-drug sensitivity predictions.

Main Methods:

  • Constructed a heterogeneous network using circRNA features, drug features, and drug structural information.
  • Employed a heterogeneous graph convolutional network (GCN) for deep feature embedding.
  • Integrated multi-instance learning (MIL) with a pseudo-metapath instance generator and BiTrans for metapath-level representation.
  • Developed an interpretable multiscale attention network for final prediction and analysis.

Main Results:

  • The MiGNN2CDS model demonstrated superior prediction accuracy compared to existing state-of-the-art methods.
  • Case studies confirmed the model's capability in predicting previously unknown circRNA-drug associations.
  • Model interpretability was validated through high-confidence meta-path analysis.

Conclusions:

  • MiGNN2CDS offers a powerful and interpretable approach for predicting circRNA-drug sensitivity.
  • The findings contribute to the development of targeted therapies by identifying key circRNA biomarkers.
  • The study provides a valuable computational tool for drug sensitivity research, with code and data publicly available.